Cargando…
“It’s only fatness, it doesn’t kill”: a qualitative study on perceptions of weight gain from use of dolutegravir-based regimens in women living with HIV in Uganda
BACKGROUND: Dolutegravir (DTG)-based regimens have been recommended by the WHO as the preferred first-line and second-line HIV treatment in all populations. Evidence suggests an association with weight gain, particularly among black women. Our study investigated perceptions of weight gain from DTG-b...
Autores principales: | Alhassan, Yussif, Twimukye, Adelline, Malaba, Thokozile, Myer, Landon, Waitt, Catriona, Lamorde, Mohammed, Colbers, Angela, Reynolds, Helen, Khoo, Saye, Taegtmeyer, Miriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210809/ https://www.ncbi.nlm.nih.gov/pubmed/35729541 http://dx.doi.org/10.1186/s12905-022-01814-x |
Ejemplares similares
-
‘I fear my partner will abandon me’: the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2022) -
Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2020) -
Engendering health systems in response to national rollout of dolutegravir-based regimens among women of childbearing potential: a qualitative study with stakeholders in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2020) -
A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy
por: Ochanda, Perez Nicholas, et al.
Publicado: (2022) -
What doesn't kill you… ?
por: Lawton, Graham
Publicado: (2021)